US Stock MarketDetailed Quotes

Actuate Therapeutics (ACTU)

Watchlist
  • 5.460
  • +0.010+0.18%
Trading Jan 23 10:17 ET
126.91MMarket Cap-5.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Actuate Therapeutics (ACTU) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
25.15%16.92M
1,746.03%6.49M
88.05%3.89M
192.08%8.64M
192.08%8.64M
--13.52M
--351.71K
--2.07M
-85.53%2.96M
--2.96M
-Cash and cash equivalents
25.15%16.92M
1,746.03%6.49M
88.05%3.89M
192.08%8.64M
192.08%8.64M
--13.52M
--351.71K
--2.07M
-85.53%2.96M
--2.96M
Other current assets
-29.77%519.24K
-1.05%195.9K
199.86%359.16K
1,434.34%566.28K
1,434.34%566.28K
--739.33K
--197.98K
--119.77K
9.37%36.91K
--36.91K
Total current assets
22.30%17.44M
1,116.79%6.69M
94.17%4.25M
207.38%9.21M
207.38%9.21M
--14.26M
--549.69K
--2.19M
-85.38%3M
--3M
Non current assets
Non current deferred assets
----
-76.27%280.34K
-54.07%234.48K
----
----
----
--1.18M
--510.5K
----
----
Other non current assets
--269.93K
----
----
--110.55K
--110.55K
----
----
----
----
----
Total non current assets
--269.93K
-76.27%280.34K
-54.07%234.48K
--110.55K
--110.55K
--0
--1.18M
--510.5K
--0
--0
Total assets
24.20%17.71M
302.63%6.97M
66.13%4.48M
211.07%9.32M
211.07%9.32M
--14.26M
--1.73M
--2.7M
-85.38%3M
--3M
Liabilities
Current liabilities
Payables
-46.55%1.25M
-46.19%3.17M
-33.16%2.64M
-43.86%1.92M
-43.86%1.92M
--2.33M
--5.89M
--3.96M
60.59%3.42M
--3.42M
-accounts payable
-46.55%1.25M
-46.19%3.17M
-33.16%2.64M
-43.86%1.92M
-43.86%1.92M
--2.33M
--5.89M
--3.96M
60.59%3.42M
--3.42M
Current accrued expenses
-30.59%4.28M
-33.71%4.64M
-4.16%5.27M
86.04%5.99M
86.04%5.99M
--6.17M
--7M
--5.5M
54.71%3.22M
--3.22M
Current debt and capital lease obligation
----
----
----
----
----
----
--6.9M
--5M
----
----
-Current debt
----
----
----
----
----
----
--6.9M
--5M
----
----
Current liabilities
-25.00%6.37M
-54.16%9.2M
-37.87%9.15M
27.19%8.8M
27.19%8.8M
--8.5M
--20.07M
--14.73M
59.28%6.92M
--6.92M
Non current liabilities
Non current accrued expenses
--0
-75.90%16.89K
-91.24%11.83K
-94.80%6.77K
-94.80%6.77K
--1.69K
--70.1K
--135.12K
50.51%130.04K
--130.04K
Derivative product liabilities
----
----
----
--0
--0
--0
--1.26M
--1.02M
21.33%988.05K
--988.05K
Preferred securities outside stock equity
----
----
----
--0
--0
--0
--94.18M
--94.18M
4.48%94.18M
--94.18M
Total non current liabilities
-0.42%404.99K
-99.56%421.88K
-99.56%416.82K
-99.57%411.76K
-99.57%411.76K
--406.68K
--95.91M
--95.74M
4.66%95.7M
--95.7M
Total liabilities
-23.88%6.78M
-91.70%9.62M
-91.34%9.57M
-91.02%9.21M
-91.02%9.21M
--8.9M
--115.99M
--110.47M
7.13%102.62M
--102.62M
Shareholders'equity
Share capital
15.00%23
900.00%20
900.00%20
900.00%20
900.00%20
--20
--2
--2
0.00%2
--2
-common stock
15.00%23
900.00%20
900.00%20
900.00%20
900.00%20
--20
--2
--2
0.00%2
--2
-Preferred stock
--0
--0
--0
--0
--0
----
----
----
--0
--0
Retained earnings
-19.15%-150.05M
-20.58%-144.65M
-22.32%-138.7M
-25.96%-132.38M
-25.96%-132.38M
---125.93M
---119.96M
---113.39M
-30.80%-105.09M
---105.09M
Paid-in capital
22.62%160.99M
2,388.38%141.99M
2,278.99%133.61M
2,322.89%132.48M
2,322.89%132.48M
--131.29M
--5.71M
--5.62M
8.40%5.47M
--5.47M
Total stockholders'equity
104.09%10.94M
97.68%-2.65M
95.28%-5.09M
100.10%104.19K
100.10%104.19K
--5.36M
---114.26M
---107.77M
-32.30%-99.63M
---99.63M
Total equity
104.09%10.94M
97.68%-2.65M
95.28%-5.09M
100.10%104.19K
100.10%104.19K
--5.36M
---114.26M
---107.77M
-32.30%-99.63M
---99.63M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 25.15%16.92M1,746.03%6.49M88.05%3.89M192.08%8.64M192.08%8.64M--13.52M--351.71K--2.07M-85.53%2.96M--2.96M
-Cash and cash equivalents 25.15%16.92M1,746.03%6.49M88.05%3.89M192.08%8.64M192.08%8.64M--13.52M--351.71K--2.07M-85.53%2.96M--2.96M
Other current assets -29.77%519.24K-1.05%195.9K199.86%359.16K1,434.34%566.28K1,434.34%566.28K--739.33K--197.98K--119.77K9.37%36.91K--36.91K
Total current assets 22.30%17.44M1,116.79%6.69M94.17%4.25M207.38%9.21M207.38%9.21M--14.26M--549.69K--2.19M-85.38%3M--3M
Non current assets
Non current deferred assets -----76.27%280.34K-54.07%234.48K--------------1.18M--510.5K--------
Other non current assets --269.93K----------110.55K--110.55K--------------------
Total non current assets --269.93K-76.27%280.34K-54.07%234.48K--110.55K--110.55K--0--1.18M--510.5K--0--0
Total assets 24.20%17.71M302.63%6.97M66.13%4.48M211.07%9.32M211.07%9.32M--14.26M--1.73M--2.7M-85.38%3M--3M
Liabilities
Current liabilities
Payables -46.55%1.25M-46.19%3.17M-33.16%2.64M-43.86%1.92M-43.86%1.92M--2.33M--5.89M--3.96M60.59%3.42M--3.42M
-accounts payable -46.55%1.25M-46.19%3.17M-33.16%2.64M-43.86%1.92M-43.86%1.92M--2.33M--5.89M--3.96M60.59%3.42M--3.42M
Current accrued expenses -30.59%4.28M-33.71%4.64M-4.16%5.27M86.04%5.99M86.04%5.99M--6.17M--7M--5.5M54.71%3.22M--3.22M
Current debt and capital lease obligation --------------------------6.9M--5M--------
-Current debt --------------------------6.9M--5M--------
Current liabilities -25.00%6.37M-54.16%9.2M-37.87%9.15M27.19%8.8M27.19%8.8M--8.5M--20.07M--14.73M59.28%6.92M--6.92M
Non current liabilities
Non current accrued expenses --0-75.90%16.89K-91.24%11.83K-94.80%6.77K-94.80%6.77K--1.69K--70.1K--135.12K50.51%130.04K--130.04K
Derivative product liabilities --------------0--0--0--1.26M--1.02M21.33%988.05K--988.05K
Preferred securities outside stock equity --------------0--0--0--94.18M--94.18M4.48%94.18M--94.18M
Total non current liabilities -0.42%404.99K-99.56%421.88K-99.56%416.82K-99.57%411.76K-99.57%411.76K--406.68K--95.91M--95.74M4.66%95.7M--95.7M
Total liabilities -23.88%6.78M-91.70%9.62M-91.34%9.57M-91.02%9.21M-91.02%9.21M--8.9M--115.99M--110.47M7.13%102.62M--102.62M
Shareholders'equity
Share capital 15.00%23900.00%20900.00%20900.00%20900.00%20--20--2--20.00%2--2
-common stock 15.00%23900.00%20900.00%20900.00%20900.00%20--20--2--20.00%2--2
-Preferred stock --0--0--0--0--0--------------0--0
Retained earnings -19.15%-150.05M-20.58%-144.65M-22.32%-138.7M-25.96%-132.38M-25.96%-132.38M---125.93M---119.96M---113.39M-30.80%-105.09M---105.09M
Paid-in capital 22.62%160.99M2,388.38%141.99M2,278.99%133.61M2,322.89%132.48M2,322.89%132.48M--131.29M--5.71M--5.62M8.40%5.47M--5.47M
Total stockholders'equity 104.09%10.94M97.68%-2.65M95.28%-5.09M100.10%104.19K100.10%104.19K--5.36M---114.26M---107.77M-32.30%-99.63M---99.63M
Total equity 104.09%10.94M97.68%-2.65M95.28%-5.09M100.10%104.19K100.10%104.19K--5.36M---114.26M---107.77M-32.30%-99.63M---99.63M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 +2.92%
Sample Name
Sample Code
 +2.36%
4
Clean Energy Fuels
CLNE
+2.19%
5
NVIDIA
NVDA
+1.52%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.21%
Sample Name
Sample Code
 +8.74%
Sample Name
Sample Code
 +4.20%
4
Pony AI
PONY
+4.09%
5
KE Holdings
BEKE
+4.07%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -